Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00053131. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy
ClinicalTrials.gov study NCT06891144. IPD Sharing: NO. Countries: 1. Publications: 0.
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1
ClinicalTrials.gov study NCT06744504. IPD Sharing: NO. Countries: 1. Publications: 0.
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project
ClinicalTrials.gov study NCT01252485. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00004215. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
ClinicalTrials.gov study NCT00006019. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia
ClinicalTrials.gov study NCT07232134. IPD Sharing: NO. Countries: 1. Publications: 0.
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00242515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06007911. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03755154. IPD Sharing: YES. Countries: 4. Publications: 0.
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
ClinicalTrials.gov study NCT00454168. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06116318. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02676323. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox)
ClinicalTrials.gov study NCT02233504. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
ClinicalTrials.gov study NCT05222984. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06448013. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada
ClinicalTrials.gov study NCT05424562. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06945042. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06265545. IPD Sharing: NO. Countries: 1. Publications: 0.
Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03513484. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.